论文部分内容阅读
本月全球药品研发进展取得成效的药物有42个,较上月减少了7个,除进入注册前阶段的药物数量与上月持平以外,进入注册阶段和Ⅲ期临床研究阶段的药品数量均较上月有所减少。进入注册阶段的有18个,比上月减少5个。其中2个为全球首次注册的新制剂,其余16个均
There were 42 pharmaceuticals that made progress in global drug development this month, a decrease of 7 from the previous month. Compared with the previous month, the number of drugs entering the registration phase and the phase Ⅲ clinical trial was significantly lower than that of the previous month The decrease last month. There were 18 registrations, a decrease of 5 from the previous month. Two of them were the first new formulations to be registered in the world, with the remaining 16 averages